Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study

Cancer Treat Rep. 1983 Dec;67(12):1137-8.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aclarubicin
  • Adult
  • Aged
  • Breast Neoplasms / drug therapy*
  • Drug Evaluation
  • Female
  • Gastrointestinal Diseases / chemically induced
  • Humans
  • Leukopenia / chemically induced
  • Middle Aged
  • Naphthacenes / adverse effects
  • Naphthacenes / therapeutic use
  • Thrombocytopenia / chemically induced

Substances

  • Naphthacenes
  • Aclarubicin